Telemedicine: A Temporary Fix or a Lasting Solution?
Telemedicine solutions have seen a rise in adoption and normalisation since the COVID-19 pandemic. Global funding for Telemedicine ventures across the world grew by 36%, with the United States contributing the most and APAC following close. The whole Telemedicine ecosystem seems to be flourishing, yet some believe this to be a knee-jerk reaction. Will Telemedicine be a permanent norm in healthcare? Join us as we track its development and challenges in future transformation in a conversation with leading industry experts.June 21 | 4.00 PM SGT
Digital Oncology: The Future of Cancer Diagnosis and Treatment
Globally, 12% of venture funding in digital health in 2020 went to Oncology-focused ventures, which was more than any other therapeutic area, including mental health. Many oncology-focused ventures in the ecosystem seek to improve diagnosis and research to improve prevention and treatment within the healthcare value chain. How has the advancement of technology impacted the study, detection and treatment of cancer? Where do we see oncology and digital health moving? Join us as we dive into the world of oncology in a conversation with leading industry experts.July 21 | 4.00 PM SGT
What you will get:
- Additional insights from Galen Growth’s Oncology report;
- A better understanding of the therapeutic focus area of Oncology;
- Real-world experience and cases;
- 25% off the Oncology report when you attend.
Speakers
Dr. Dean Ho Director, The N.1 Institute for Health
Dr. Huren Sivaraj Co-Founder & CEO, Oncoshot
Martin Lim Founder & CEO, ONWARD Health Research
Moderators
Dr. Hong-Ling Xue Asia Pacific Medical Director, Solid Tumors, Novartis Oncology
Helene Champoux COO, Galen Growth